XML 71 R45.htm IDEA: XBRL DOCUMENT v3.20.4

Revenue (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020 USD ($) segment	Dec. 31, 2019 USD ($) segment	Dec. 31, 2018 USD ($) segment
Revenue
Number of reportable segments | segment	4	4	4
Net sales	$ 34,608	$ 31,904	$ 30,578
Minimum
Revenue
Settlement of rebate after sale	1 month
Period cash discounts are known after sale	15 days
Maximum
Revenue
Settlement of rebate after sale	6 months
Period cash discounts are known after sale	30 days
U.S.
Revenue
Net sales	$ 13,022	11,398	10,839
Int'l
Revenue
Net sales	21,586	20,506	19,739
Established Pharmaceutical Products
Revenue
Net sales	4,303	4,486	4,422
Established Pharmaceutical Products | Int'l
Revenue
Net sales	4,303	4,486	4,422
Nutritional Products
Revenue
Net sales	7,647	7,409	7,229
Nutritional Products | U.S.
Revenue
Net sales	3,279	3,110	3,075
Nutritional Products | Int'l
Revenue
Net sales	4,368	4,299	4,154
Diagnostic Products
Revenue
Net sales	10,805	7,713	7,495
Diagnostic Products | U.S.
Revenue
Net sales	4,774	2,887	2,717
Diagnostic Products | Int'l
Revenue
Net sales	6,031	4,826	4,778
Medical Devices
Revenue
Net sales	11,787	12,239	11,370
Medical Devices | U.S.
Revenue
Net sales	4,931	5,374	5,011
Medical Devices | Int'l
Revenue
Net sales	6,856	6,865	6,359
Other
Revenue
Net sales	66	57	62
Key Emerging Markets | Established Pharmaceutical Products
Revenue
Net sales	3,209	3,392	3,363
Key Emerging Markets | Established Pharmaceutical Products | Int'l
Revenue
Net sales	3,209	3,392	3,363
Other | Established Pharmaceutical Products
Revenue
Net sales	1,094	1,094	1,059
Other | Established Pharmaceutical Products | Int'l
Revenue
Net sales	1,094	1,094	1,059
Other | Other
Revenue
Net sales	66	57	62
Other | Other | U.S.
Revenue
Net sales	38	27	36
Other | Other | Int'l
Revenue
Net sales	28	30	26
Pediatric Nutritionals | Nutritional Products
Revenue
Net sales	4,127	4,161	4,097
Pediatric Nutritionals | Nutritional Products | U.S.
Revenue
Net sales	1,987	1,879	1,843
Pediatric Nutritionals | Nutritional Products | Int'l
Revenue
Net sales	2,140	2,282	2,254
Adult Nutritionals | Nutritional Products
Revenue
Net sales	3,520	3,248	3,132
Adult Nutritionals | Nutritional Products | U.S.
Revenue
Net sales	1,292	1,231	1,232
Adult Nutritionals | Nutritional Products | Int'l
Revenue
Net sales	2,228	2,017	1,900
Core Laboratory | Diagnostic Products
Revenue
Net sales	4,475	4,656	4,386
Core Laboratory | Diagnostic Products | U.S.
Revenue
Net sales	1,166	1,086	985
Core Laboratory | Diagnostic Products | Int'l
Revenue
Net sales	3,309	3,570	3,401
Molecular | Diagnostic Products
Revenue
Net sales	1,438	442	484
Molecular | Diagnostic Products | U.S.
Revenue
Net sales	621	149	152
Molecular | Diagnostic Products | Int'l
Revenue
Net sales	817	293	332
Point of Care | Diagnostic Products
Revenue
Net sales	516	561	553
Point of Care | Diagnostic Products | U.S.
Revenue
Net sales	369	438	432
Point of Care | Diagnostic Products | Int'l
Revenue
Net sales	147	123	121
Rapid Diagnostics | Diagnostic Products
Revenue
Net sales	4,376	2,054	2,072
Rapid Diagnostics | Diagnostic Products | U.S.
Revenue
Net sales	2,618	1,214	1,148
Rapid Diagnostics | Diagnostic Products | Int'l
Revenue
Net sales	1,758	840	924
Rhythm Management | Medical Devices
Revenue
Net sales	1,914	2,144	2,198
Rhythm Management | Medical Devices | U.S.
Revenue
Net sales	903	1,057	1,105
Rhythm Management | Medical Devices | Int'l
Revenue
Net sales	1,011	1,087	1,093
Electrophysiology | Medical Devices
Revenue
Net sales	1,578	1,721	1,561
Electrophysiology | Medical Devices | U.S.
Revenue
Net sales	660	742	678
Electrophysiology | Medical Devices | Int'l
Revenue
Net sales	918	979	883
Heart Failure | Medical Devices
Revenue
Net sales	740	769	646
Heart Failure | Medical Devices | U.S.
Revenue
Net sales	547	574	467
Heart Failure | Medical Devices | Int'l
Revenue
Net sales	193	195	179
Vascular | Medical Devices
Revenue
Net sales	2,339	2,850	2,929
Vascular | Medical Devices | U.S.
Revenue
Net sales	853	1,047	1,126
Vascular | Medical Devices | Int'l
Revenue
Net sales	1,486	1,803	1,803
Structural Heart | Medical Devices
Revenue
Net sales	1,247	1,400	1,239
Structural Heart | Medical Devices | U.S.
Revenue
Net sales	540	616	488
Structural Heart | Medical Devices | Int'l
Revenue
Net sales	707	784	751
Neuromodulation | Medical Devices
Revenue
Net sales	702	831	864
Neuromodulation | Medical Devices | U.S.
Revenue
Net sales	564	660	690
Neuromodulation | Medical Devices | Int'l
Revenue
Net sales	138	171	174
Diabetes Care | Medical Devices
Revenue
Net sales	3,267	2,524	1,933
Diabetes Care | Medical Devices | U.S.
Revenue
Net sales	864	678	457
Diabetes Care | Medical Devices | Int'l
Revenue
Net sales	$ 2,403	$ 1,846	$ 1,476

X

- Definition

Period cash discounts become known after sale, in 'PnYnMnDTnHnMnS' format, for example, ''P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	abt_PeriodCashDiscountsBecomeKnown
Namespace Prefix:	abt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The period for settlement of rebate after sale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	abt_PeriodForSettlementOfRebateAfterSale
Namespace Prefix:	abt_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599

+ Details

Name:	us-gaap_NumberOfReportableSegments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_StatementGeographicalAxis=us-gaap_NonUsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=abt_EstablishedPharmaceuticalProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=abt_NutritionalProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=abt_DiagnosticProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=abt_MedicalDevicesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_KeyEmergingMarketsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_OtherMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_PediatricNutritionalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_AdultNutritionalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_CoreLaboratoryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_MolecularMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_PointOfCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_RapidDiagnosticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_RhythmManagementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_ElectrophysiologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_HeartFailureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_VascularProductsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_StructuralHeartMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_NeuromodulationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsegmentsAxis=abt_DiabetesCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: